Table 2 Baseline clinical characteristics of the study cohort.

From: lncRNA RP11-199F11.2 promotes high-grade serous ovarian cancer cell proliferation by regulating cuproptosis through FDX1

Variable

HGSOC (n = 30)

Normal (n = 26)

P value

Age (years)

58.3 ± 7.2

56.8 ± 8.0

0.47

FIGO stage (III/IV)

24 (80%)

–

–

Lymph node metastasis

18 (60%)

0 (0%)

 < 0.001**

CA125 (U/ml)

742 (353–1215)

21 (14–29)

 < 0.001**

TP53 mutation

25 (83%)

–

–

  1. Multivariable logistic regression showed that high RP11 expression was independently associated with advanced FIGO stage (OR = 3.52, 95% CI 1.14–10.91, P = 0.029, adjusted for age, CA125 and TP53 mutation).
Back to article page